Kelsy Ketchum

The firm's core laboratory revenues declined 1 percent, while molecular laboratory sales were up 4 percent.

The firm also reported its Life Sciences segment revenues fell 4 percent in the quarter, while Diagnostics revenues decreased 3 percent.

The firms are developing a workflow that will include Cepheid's sample and library preparation, nanopore sequencing, and automated data analysis.

The firm's CEO said that the US and China will be most affected by the tariffs with an impact of a "few hundred million dollars" in the second half of the year.

IL-6 outperformed traditional sepsis biomarkers like C-reactive protein and procalcitonin in the cohorts.

In a session at the conference, multiple researchers presented data on their implementation of metagenomic sequencing for diagnostic use cases.

The firm recently announced agreements with Labcorp and Quest Diagnostics to provide its devices for self-collection of vaginal swab specimens.

The assays measure phosphorylated tau 181 and apolipoprotein 4 to rule out whether a patient has Alzheimer's disease.

The firm uses proprietary dyes and Raman spectroscopy to detect pancreatic cysts from small sample volumes.

The automated DxC 500 I analyzer has a throughput of up to 800 clinical chemistry tests and 100 immunoassays per hour.